vs
Side-by-side financial comparison of FIRSTSUN CAPITAL BANCORP (FSUN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $110.0M, roughly 1.5× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs -82.0%, a 101.6% gap on every dollar of revenue. Over the past eight quarters, FIRSTSUN CAPITAL BANCORP's revenue compounded faster (6.9% CAGR vs -11.5%).
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
FSUN vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.0M | $164.7M |
| Net Profit | $21.6M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 19.6% | -82.0% |
| Revenue YoY | — | -22.7% |
| Net Profit YoY | -8.4% | -104.8% |
| EPS (diluted) | $0.76 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.0M | — | ||
| Q4 25 | $110.2M | $164.7M | ||
| Q3 25 | $107.3M | $211.0M | ||
| Q2 25 | $105.6M | $178.9M | ||
| Q1 25 | $96.2M | $1.2B | ||
| Q4 24 | $98.7M | $213.2M | ||
| Q3 24 | $98.2M | $196.8M | ||
| Q2 24 | $96.2M | $186.7M |
| Q1 26 | $21.6M | — | ||
| Q4 25 | $24.8M | $-135.0M | ||
| Q3 25 | $23.2M | $15.9M | ||
| Q2 25 | $26.4M | $-64.8M | ||
| Q1 25 | $23.6M | $866.6M | ||
| Q4 24 | $16.4M | $-65.9M | ||
| Q3 24 | $22.4M | $-106.7M | ||
| Q2 24 | $24.6M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | 29.0% | -43.3% | ||
| Q3 25 | 26.4% | 1.4% | ||
| Q2 25 | 31.2% | -19.5% | ||
| Q1 25 | 30.9% | 82.5% | ||
| Q4 24 | 20.4% | -76.2% | ||
| Q3 24 | 29.1% | -27.7% | ||
| Q2 24 | 32.3% | -21.5% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 22.5% | -82.0% | ||
| Q3 25 | 21.6% | 7.5% | ||
| Q2 25 | 25.0% | -36.3% | ||
| Q1 25 | 24.5% | 73.7% | ||
| Q4 24 | 16.6% | -30.9% | ||
| Q3 24 | 22.8% | -54.2% | ||
| Q2 24 | 25.5% | -53.1% |
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.89 | $-1.63 | ||
| Q3 25 | $0.82 | $0.20 | ||
| Q2 25 | $0.93 | $-0.83 | ||
| Q1 25 | $0.83 | $10.04 | ||
| Q4 24 | $0.57 | $-0.85 | ||
| Q3 24 | $0.79 | $-1.39 | ||
| Q2 24 | $0.88 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $413.7M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $-205.3M |
| Total Assets | $8.6B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $413.7M | — | ||
| Q4 25 | $652.6M | $1.9B | ||
| Q3 25 | $659.9M | $1.7B | ||
| Q2 25 | $785.1M | $2.0B | ||
| Q1 25 | $621.4M | $2.0B | ||
| Q4 24 | $615.9M | $1.1B | ||
| Q3 24 | $573.7M | $1.0B | ||
| Q2 24 | $535.8M | $1.1B |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $-205.3M | ||
| Q3 25 | $1.1B | $-155.8M | ||
| Q2 25 | $1.1B | $-206.5M | ||
| Q1 25 | $1.1B | $-185.8M | ||
| Q4 24 | $1.0B | $-1.1B | ||
| Q3 24 | $1.0B | $-1.1B | ||
| Q2 24 | $996.6M | $-980.2M |
| Q1 26 | $8.6B | — | ||
| Q4 25 | $8.5B | $2.9B | ||
| Q3 25 | $8.5B | $2.6B | ||
| Q2 25 | $8.4B | $2.6B | ||
| Q1 25 | $8.2B | $2.7B | ||
| Q4 24 | $8.1B | $1.7B | ||
| Q3 24 | $8.1B | $1.8B | ||
| Q2 24 | $8.0B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $111.5M | $-34.3M | ||
| Q3 25 | $49.4M | $-66.3M | ||
| Q2 25 | $15.0M | $-58.3M | ||
| Q1 25 | $26.4M | $870.1M | ||
| Q4 24 | $101.1M | $-30.0M | ||
| Q3 24 | $48.1M | $-77.0M | ||
| Q2 24 | $20.9M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | $104.0M | $-36.6M | ||
| Q3 25 | $47.6M | $-69.7M | ||
| Q2 25 | $13.0M | $-59.6M | ||
| Q1 25 | $24.3M | $868.4M | ||
| Q4 24 | $95.7M | $-33.8M | ||
| Q3 24 | $47.1M | $-77.5M | ||
| Q2 24 | $19.9M | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | 94.3% | -22.3% | ||
| Q3 25 | 44.4% | -33.1% | ||
| Q2 25 | 12.3% | -33.3% | ||
| Q1 25 | 25.3% | 73.8% | ||
| Q4 24 | 97.0% | -15.8% | ||
| Q3 24 | 47.9% | -39.4% | ||
| Q2 24 | 20.6% | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 1.4% | ||
| Q3 25 | 1.6% | 1.6% | ||
| Q2 25 | 1.9% | 0.7% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 5.5% | 1.8% | ||
| Q3 24 | 1.1% | 0.3% | ||
| Q2 24 | 1.1% | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.49× | — | ||
| Q3 25 | 2.13× | -4.17× | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 1.12× | 1.00× | ||
| Q4 24 | 6.18× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 0.85× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
PTCT
Segment breakdown not available.
